TTrialPathMatch Me to Trials
← Back to trials
RecruitingHematologic MalignanciesInherited Disorders of MetabolismInherited Abnormalities of Platelets

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Eligible age

All ages

Accepts

All genders

Locations

41 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Sponsor: Center for International Blood and Marrow Transplant Research

You may qualify if…

  • ✓ Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment
  • ✓ Signed informed consent (and signed assent, if applicable) obtained prior to study enrollment
  • ✓ Pediatric and adult patients of any age

You may not qualify if…

  • ✕ Patients who are receiving only licensed CBUs
  • ✕ Cord blood transplant recipients at international transplant centers
  • ✕ Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)
  • ✕ Patients whose selected unlicensed CBU(s) will be more than minimally manipulated

Where it's recruiting

Alabama

Birmingham

Arizona

Gilbert · Phoenix · Tucson

Arkansas

Little Rock

California

Duarte · Glendale · La Jolla · Loma Linda …

Colorado

Aurora · Denver

Connecticut

New Haven

Delaware

Brandywine

District of Columbia

Washington D.C.

Florida

Gainesville · Jacksonville · Miami · Orlando …

Georgia

Atlanta · Augusta

Hawaii

Honolulu

Illinois

Chicago · Maywood · Park Ridge · Zion

Source: ClinicalTrials.gov · NCT01351545 · last updated 2026-07-06

A Multicenter Access and Distribution Protocol for Unlicensed Cryopres · TrialPath